Ultralife Corporation
ULBI
$7.79
$0.141.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3,925.77% | -572.87% | -70.39% | -35.49% | -93.17% |
| Total Depreciation and Amortization | 10.86% | 42.76% | 39.57% | 39.98% | 22.05% |
| Total Amortization of Deferred Charges | 40.43% | 450.00% | 325.00% | 306.25% | 193.75% |
| Total Other Non-Cash Items | 2,709.83% | -400.00% | -47.03% | -29.00% | 105.95% |
| Change in Net Operating Assets | -270.63% | -93.83% | -22.97% | 89.50% | 182.05% |
| Cash from Operations | -51.12% | -95.83% | -33.50% | 4,258.02% | 25.25% |
| Capital Expenditure | -45.54% | -67.51% | -205.56% | -140.59% | 39.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.18% | -66.84% | -205.56% | -140.59% | -4,738.61% |
| Total Debt Issued | -- | -- | -- | -- | 5,400.00% |
| Total Debt Repaid | 91.45% | 82.94% | 79.60% | -37.40% | -435.67% |
| Issuance of Common Stock | -100.00% | 54.17% | -95.12% | -- | -81.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Financing | -101.50% | 84.03% | 77.77% | -471.35% | 15,276.08% |
| Foreign Exchange rate Adjustments | 1,038.89% | -2,733.33% | 182.61% | -11.24% | 87.92% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.25% | -2,101.19% | 165.18% | 1,141.90% | -91.81% |